selected publications
- Multi-CpG linear regression models to accurately predict paclitaxel and docetaxel activity in cancer cell lines. Advances in cancer research. 2022 Review GET IT
- Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning. Genes. 2022 Academic Article GET IT
-
A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer Metastasis.
Cancers.
2021
Academic Article
GET IT
Times cited: 183 -
Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression.
International journal of molecular sciences.
2021
Academic Article
GET IT
Times cited: 5 -
MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types.
Current cancer drug targets.
2021
Academic Article
GET IT
Times cited: 5 -
The Epigenetic Factors that Drive Cancer Drug Resistance.
Current cancer drug targets.
2021
Editorial Article
GET IT
Times cited: 1 -
Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.
The Journal of molecular diagnostics : JMD.
2020
Academic Article
GET IT
Times cited: 5 -
Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay.
Human mutation.
2020
Academic Article
GET IT
Times cited: 7 -
Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection.
BMC cancer.
2020
Academic Article
GET IT
Times cited: 11 -
Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.
Oncogene.
2019
Academic Article
GET IT
Times cited: 22 -
Can CpG methylation serve as surrogate markers for immune infiltration in cancer?.
Advances in cancer research.
2019
Review
GET IT
Times cited: 19 -
Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors.
Advances in cancer research.
2019
Academic Article
GET IT
Times cited: 10 -
Immune infiltration, glioma stratification, and therapeutic implications.
Translational cancer research.
2016
Academic Article
GET IT
Times cited: 9 -
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Advances in cancer research.
2015
Review
GET IT
Times cited: 23 -
Analysis of global changes in gene expression induced by human polynucleotide phosphorylase (hPNPase(old-35)).
Journal of cellular physiology.
2014
Academic Article
GET IT
Times cited: 7 -
Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis.
Cancer research.
2014
Academic Article
GET IT
Times cited: 52 -
Evolutionary dynamics of Polynucelotide phosphorylases.
Molecular phylogenetics and evolution.
2014
Academic Article
GET IT
Times cited: 2 -
MDA-9/syntenin is a key regulator of glioma pathogenesis.
Neuro-oncology.
2013
Academic Article
GET IT
Times cited: 54 -
Identification of genes potentially regulated by human polynucleotide phosphorylase (hPNPase old-35) using melanoma as a model.
PloS one.
2013
Academic Article
GET IT
Times cited: 11 -
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.
British journal of cancer.
2012
Academic Article
GET IT
Times cited: 30 -
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition.
Annals of surgical oncology.
2011
Review
GET IT
Times cited: 51 -
Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.
The Journal of molecular diagnostics : JMD.
2010
Review
GET IT
Times cited: 23 -
Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer.
Proceedings of the National Academy of Sciences of the United States of America.
2009
Academic Article
GET IT
Times cited: 291 -
Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.
Cancer research.
2009
Review
GET IT
Times cited: 43 -
CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2008
Academic Article
GET IT
Times cited: 89 -
BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.
Cancer chemotherapy and pharmacology.
2008
Academic Article
GET IT
Times cited: 13 -
The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
Current cancer drug targets.
2008
Academic Article
GET IT
Times cited: 35 -
The signatures of autozygosity among patients with colorectal cancer.
Cancer research.
2008
Academic Article
GET IT
Times cited: 43 -
GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2006
Academic Article
GET IT
Times cited: 56 -
Relationship of gene expression and chromosomal abnormalities in colorectal cancer.
Cancer research.
2006
Academic Article
GET IT
Times cited: 220 -
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations.
Molecular cancer therapeutics.
2004
Academic Article
GET IT
Times cited: 36 -
Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.
Molecular cancer therapeutics.
2002
Academic Article
GET IT
Times cited: 36 -
Mutagenicity of a single 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-aminopyrene in Escherichia coli located in a GGC sequence.
Mutagenesis.
2001
Academic Article
GET IT
Times cited: 10 -
Mutagenicity of the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-aminopyrene in Escherichia coli located in a nonrepetitive CGC sequence.
Chemical research in toxicology.
2000
Academic Article
GET IT
Times cited: 14 -
Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells.
Chemical research in toxicology.
1997
Academic Article
GET IT
Times cited: 74